Aurinia Pharmaceuticals I...

NASDAQ: AUPH · Real-Time Price · USD
12.27
0.18 (1.49%)
At close: Aug 15, 2025, 3:59 PM
12.44
1.43%
After-hours: Aug 15, 2025, 07:44 PM EDT

Aurinia Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
60.64M 39.84M 5.75M -22.55M -50.35M -62.56M -78.02M -77.19M -72.73M -96.76M -108.18M -115.46M -156.72M -168.22M -180.97M -155.72M -139.53M -122.04M
Depreciation & Amortization
7.16M 9.7M 9.69M 9.78M 19.9M 15.78M 11.65M 6.92M 2.46M 2.58M 2.71M 3.17M 3.05M 2.91M 2.76M 2.48M 2.3M 2.09M
Stock-Based Compensation
19.3M 22.45M 31.6M 34.42M 37.9M 41.58M 45.31M 40.45M 36.96M 34.74M 32.3M 33.98M 32.75M 30.45M 31.24M 27.81M 25.33M 21.78M
Other Working Capital
24.84M 19.49M 33.42M 21.29M 731.82K 4.71M 20.67M 14.32M 20.71M 16.16M -371K -727K -10.64M -8.9M -7.56M -1.24M 14.91M 17.81M
Other Non-Cash Items
-100.43K -12.09M 9.06M 34.78M 39.84M 36M 14.38M -6.5M -5.28M -3.45M 462K 2.95M 16.32M 14.53M 10.9M 19.75M -2.2M 1.49M
Deferred Income Tax
n/a n/a n/a -12.9M -15.22M -20.82M -20.82M -7.92M -5.6M n/a n/a n/a n/a n/a n/a n/a -8.76M -5.81M
Change in Working Capital
2.28M 8.09M 22.3M 19.59M 738.29K -2.96M -5.45M 6.92M 4.79M -1.58M -6.82M -40.54M -36.18M -30.56M -21.63M -22.89M -4.5M -6.53M
Operating Cash Flow
92.68M 64.31M 44.41M 29.11M -1.2M -19.89M -32.96M -37.32M -39.41M -64.45M -79.53M -115.9M -140.79M -150.9M -157.69M -128.57M -118.6M -103.21M
Capital Expenditures
-295.16K -280.48K -275.48K -274.05K -40.05K -183.73K -680.73K -552K -694.68K -506.2K -76.2K -190.2K -215.52K -399K -1.5M -3.65M -5.95M -5.86M
Cash Acquisitions
n/a n/a n/a n/a n/a 50K -167.21M -167.21M -167.17M -167.18M 76.2K 76.2K -120.48K -159K -1.2M -1.2M -1.04M -1.04M
Purchase of Investments
-467.37M -516.56M -545.83M -599.09M -576.6M -496.03M -517.17M -500.02M -547.48M -502.89M -523.99M -499.31M -454.93M -487.29M -438.96M -342.83M -387.98M -306.21M
Sales Maturities Of Investments
52.71M 76.5M 123.97M 131.65M 561.2M 525.68M 522.94M 509.49M 526.93M 521.52M 464.32M 436.78M 415.45M 404.05M 354.43M 285.08M 216.71M 113.02M
Other Investing Acitivies
461.37M 461.33M 510.56M 510.49M 49.32M 37.45M 155.47M 154.82M 154.43M 166.3M -53.89M -53.38M -59.12M -59.26M -19.21M -19.92M -14.72M -14.57M
Investing Cash Flow
46.41M 20.99M 39.19M -6.23M -15.36M 17.73M -6.64M -3.47M -33.98M 17.25M -60.63M -63.1M -45.69M -89.64M -103.87M -79.24M -189.06M -210.89M
Debt Repayment
-8.76M -8.76M -5.99M -9.5M -6.54M -6.54M -6.54M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-111.42M -74.99M -40.37M -18.57M -18.43M -12.3M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
3.62M -115K -2.87M -3.69M -7.41M -4.13M 256.3K -21.7K 3.47M 3.67M 2.43M 10.73M 19.81M 19.75M 24.37M 16.63M 9.07M 8.75M
Financial Cash Flow
-119.5M -83.21M -48.93M -31.41M -31.02M -21.78M -5.09M 1.14M 3.44M 3.64M 2.41M 207.44M 216.55M 216.49M 221.11M 16.63M 196.81M 196.48M
Net Cash Flow
19.59M 1.97M 34.56M -9.26M -48.3M -24.54M -45.3M -39.66M -69.92M -43.54M -137.73M 28.46M 30.07M -24.05M -40.45M -191.17M -110.85M -117.62M
Free Cash Flow
92.38M 64.02M 44.13M 28.84M -1.24M -20.07M -33.64M -37.88M -40.1M -64.96M -79.61M -116.09M -141M -151.3M -159.19M -132.22M -124.55M -109.07M